• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三种免费软件包在 F-FDG PET 纹理特征计算中的比较。

Comparison of three freeware software packages for F-FDG PET texture feature calculation.

机构信息

Institute of Biostructures and Bioimaging, National Research Council (CNR), Via Tommaso de Amicis, 95, 80145, Napoli, Italy.

出版信息

Jpn J Radiol. 2021 Jul;39(7):710-719. doi: 10.1007/s11604-021-01100-0. Epub 2021 Feb 17.

DOI:10.1007/s11604-021-01100-0
PMID:33595789
Abstract

PURPOSE

To compare texture feature estimates obtained from F-FDG-PET images using three different software packages.

METHODS

PET images from 15 patients with head and neck cancer were processed with three different freeware software: CGITA, LIFEx, and Metavol. For each lesion, 38 texture features were extracted from each software package. To evaluate the statistical agreement among the features across packages a non-parametric Kruskal-Wallis test was used. Differences in the features between each couple of software were assessed using a subsequent Dunn test. Correlation between texture features was evaluated via the Spearman coefficient.

RESULTS

Twenty-three of 38 features showed a significant agreement across the three software (P < 0.05). The agreement was better between LIFEx vs. Metavol (36 of 38) and worse between CGITA and Metavol (24 of 38), and CGITA vs. LIFEx (23 of 38). All features resulted correlated (ρ >  = 0.70, P < 0.001) in comparing LIFEx vs. Metavol. Seven of 38 features were found not in agreement and slightly or not correlated (ρ < 0.70, P < 0.001) in comparing CGITA vs. LIFEx, and CGITA vs. Metavol.

CONCLUSION

Some texture discrepancies across software packages exist. Our findings reinforce the need to continue the standardization process, and to succeed in building a reference dataset to be used for comparisons.

摘要

目的

比较三种不同软件包从 F-FDG-PET 图像中提取的纹理特征估计值。

方法

对头颈癌患者的 15 例 PET 图像进行处理,使用三种不同的免费软件:CGITA、LIFEx 和 Metavol。对于每个病灶,从每个软件包中提取 38 个纹理特征。为了评估特征在软件包之间的统计一致性,使用非参数 Kruskal-Wallis 检验。使用后续 Dunn 检验评估软件之间特征的差异。通过 Spearman 系数评估纹理特征之间的相关性。

结果

38 个特征中有 23 个在三个软件之间具有显著一致性(P < 0.05)。LIFEx 与 Metavol 之间的一致性更好(36 个),CGITA 与 Metavol 之间的一致性更差(24 个),CGITA 与 LIFEx 之间的一致性最差(23 个)。在比较 LIFEx 与 Metavol 时,所有特征均呈高度相关(ρ> = 0.70,P < 0.001)。在比较 CGITA 与 LIFEx 时,有 7 个特征不一致,且相关性较弱或不相关(ρ< 0.70,P < 0.001);在比较 CGITA 与 Metavol 时也存在类似情况。

结论

不同软件包之间存在一些纹理差异。我们的发现强调了需要继续进行标准化过程,并成功构建用于比较的参考数据集。

相似文献

1
Comparison of three freeware software packages for F-FDG PET texture feature calculation.三种免费软件包在 F-FDG PET 纹理特征计算中的比较。
Jpn J Radiol. 2021 Jul;39(7):710-719. doi: 10.1007/s11604-021-01100-0. Epub 2021 Feb 17.
2
Reproducibility of the principal component analysis (PCA)-based data-driven respiratory gating on texture features in non-small cell lung cancer patients with F-FDG PET/CT.基于主成分分析(PCA)的数据驱动呼吸门控在非小细胞肺癌患者 F-FDG PET/CT 纹理特征中的可重复性。
J Appl Clin Med Phys. 2023 May;24(5):e13967. doi: 10.1002/acm2.13967. Epub 2023 Mar 21.
3
Multi-site quality and variability analysis of 3D FDG PET segmentations based on phantom and clinical image data.基于体模和临床图像数据的3D FDG PET分割的多中心质量与变异性分析
Med Phys. 2017 Feb;44(2):479-496. doi: 10.1002/mp.12041.
4
The impact of image reconstruction settings on 18F-FDG PET radiomic features: multi-scanner phantom and patient studies.图像重建设置对 18F-FDG PET 放射组学特征的影响:多扫描仪体模和患者研究。
Eur Radiol. 2017 Nov;27(11):4498-4509. doi: 10.1007/s00330-017-4859-z. Epub 2017 May 31.
5
Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MR.基于[18F]-FDG 的 PET/CT 与 PET/MR 影像中影像组学特征的可互换性。
Med Phys. 2019 Apr;46(4):1677-1685. doi: 10.1002/mp.13422. Epub 2019 Feb 22.
6
Clinical utility of texture analysis of 18F-FDG PET/CT in patients with Stage I lung cancer treated with stereotactic body radiotherapy.18F-FDG PET/CT纹理分析在接受立体定向体部放疗的I期肺癌患者中的临床应用价值
J Radiat Res. 2017 Nov 1;58(6):862-869. doi: 10.1093/jrr/rrx050.
7
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions.FDG PET 和 CT 影像组学特征区分原发性和转移性肺病变的能力。
Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1649-1660. doi: 10.1007/s00259-018-3987-2. Epub 2018 Apr 6.
8
Clinical impact of F-FDG positron emission tomography/CT on adenoid cystic carcinoma of the head and neck.¹⁸F-FDG正电子发射断层扫描/计算机断层扫描对头颈部腺样囊性癌的临床影响
Head Neck. 2017 Mar;39(3):447-455. doi: 10.1002/hed.24605. Epub 2016 Oct 11.
9
Use of Diffusion-Weighted Imaging and F-Fluorodeoxyglucose Positron Emission Tomography Combined With Computed Tomography in the Response Assessment for (Chemo)radiotherapy in Head and Neck Squamous Cell Carcinoma.弥散加权成像和 F-氟代脱氧葡萄糖正电子发射断层扫描与计算机断层扫描联合应用于头颈部鳞状细胞癌放化疗反应评估。
Clin Oncol (R Coll Radiol). 2018 Dec;30(12):780-792. doi: 10.1016/j.clon.2018.09.007. Epub 2018 Oct 11.
10
Using neighborhood gray tone difference matrix texture features on dual time point PET/CT images to differentiate malignant from benign FDG-avid solitary pulmonary nodules.基于双时相 PET/CT 图像邻域灰度差矩阵纹理特征鉴别良恶性 FDG 摄取孤立性肺结节。
Cancer Imaging. 2019 Aug 16;19(1):56. doi: 10.1186/s40644-019-0243-3.

引用本文的文献

1
Diagnosing postoperative lymph node metastasis in thyroid cancer with multimodal radiomics and clinical features.利用多模态影像组学和临床特征诊断甲状腺癌术后淋巴结转移
Digit Health. 2024 Feb 20;10:20552076241233244. doi: 10.1177/20552076241233244. eCollection 2024 Jan-Dec.
2
From FDG and beyond: the evolving potential of nuclear medicine.从氟代脱氧葡萄糖(FDG)及其他方面:核医学不断发展的潜力
Ann Nucl Med. 2023 Nov;37(11):583-595. doi: 10.1007/s12149-023-01865-6. Epub 2023 Sep 25.

本文引用的文献

1
Development and evaluation of an open-source software package "CGITA" for quantifying tumor heterogeneity with molecular images.开发和评估一种开源软件包“CGITA”,用于定量分析分子图像中的肿瘤异质性。
Biomed Res Int. 2014;2014:248505. doi: 10.1155/2014/248505. Epub 2014 Mar 17.
2
Tumor heterogeneity.肿瘤异质性
Cancer Res. 1984 Jun;44(6):2259-65.